GLAXF - GlaxoSmithKline: Q3 Review And The Way Forward
Introduction:
GlaxoSmithKline Plc (OTCPK:GLAXF) is a global healthcare conglomerate that ranks among the top 10 pharmaceutical companies in the world. Headquartered in the UK, it operates through three business segments namely Pharmaceuticals, Vaccines and Consumer Healthcare. GLAXF's share currently trades near $19 and has witnessed significant volatility in prices during the past 12 months (Figure-1).
Figure-1 (Source: SA)
Thesis:
In this article, I have compared GLAXF with selected competitors based on valuation, earnings, dividends and margins. I have also included a review of the performance during Q3 2018. This